Add BrightSurf on Google Email

Unfolded Protein Response pathway offers new targets to treat bone weakness in cancer patients

Researchers identify three primary UPR pathways and their downstream cascades, which play a crucial role in the differentiation of osteoblasts and osteoclasts. Targeting these pathways with emerging drugs may alleviate bone-related events and kill tumors localized in bones.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalBone Research·TypeLiterature review·DateSep 25, 2025

An algorithm that predicts whether pancreatic cancer has spread to other organs could help avoid unnecessary surgeries

A new algorithm developed by Núria Malats and her team can accurately predict the presence of metastasis in pancreatic cancer using medical images. The PMPD algorithm has shown promising results, classifying 56% of metastases with high accuracy and potentially avoiding unnecessary surgeries.

Preventing corruption in the lymph nodes

Research by Angela Riedel and team identified fibroblastic reticulum cells as main players in reprogramming lymph nodes, corrupting monocytes and blocking T cell activity. Targeted TLR4 blockade combined with PD1 immunotherapy can restore T-cell activity and reduce distant metastasis.

SourceUniversity of Würzburg·JournalImmunity·TypeExperimental study·DateSep 16, 2025

Predicting where deadly brain cancer may spread next

Virginia Tech researchers create method combining MRI, fluid dynamics, and algorithm to identify hidden glioblastoma cells. The technique uses fluid flow patterns to predict tumor re-growth, allowing for more aggressive surgical approaches. This technology has potential to improve cancer treatment outcomes

SourceVirginia Tech·Journalnpj Biomedical Innovations·TypeExperimental study·DateSep 9, 2025

Sizing up a weakness in synovial sarcoma’s genes

Researchers at Sanford Burnham Prebys Medical Discovery Institute found that using a drug as a blocker to outcompete the SUMO2 protein may be a winning strategy against synovial sarcoma. This approach aims to reverse aberrant epigenetic rewiring driven by the SS18::SSX fusion oncoproteins and impair sarcomagenesis.

SourceSanford Burnham Prebys·JournalThe EMBO Journal·TypeExperimental study·DateSep 4, 2025

Scientists suggest new reason melanoma cells become more deadly

Scientists discovered that human melanoma cancer cells behave like stem cells when forced through channels narrower than 10 micrometres, gaining traits to survive, spread, and form new tumours. Researchers created a biomedical device to simulate blood flow through narrow blood vessels, showing the mechanical pressure makes cancer cells...

SourceUniversity of New South Wales·JournalNature Communications·TypeExperimental study·DateSep 4, 2025

Study advances understanding of rare type of lung cancer

A recent study published in Nature Communications provides a comprehensive characterization of Large Cell Neuroendocrine Carcinoma (LCNEC), a rare and aggressive type of lung cancer. The research team analyzed data from 590 patients and found that LCNEC shares features with other types of lung cancer, yet has distinct aspects. They ide...

SourceUniversity of Oklahoma·JournalNature Communications·TypeData/statistical analysis·DateAug 20, 2025

What makes cells migrate – and what can stop them

A team of scientists from the University of Konstanz has identified the PPM1F enzyme as essential for cell migration in both embryonic development and tumor cell invasion. The study found that increased levels of PPM1F enhance the invasive potential of cancer cells, while its absence impairs cell adhesion and migration.

SourceUniversity of Konstanz·JournalBMC Biology·DateJul 24, 2025

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

Researchers at Mass General Brigham found that targeted radiation was successful in treating patients with brain metastases, resulting in a lower neurological death rate and reduced need for subsequent whole brain radiation. This study supports personalized treatment approaches to maintain quality of life while managing brain metastases.

SourceMass General Brigham·JournalJournal of Clinical Oncology·TypeExperimental study·DateJul 11, 2025

Study deepens understanding of cell migration, important for potential medical advances

Researchers at the University of Maryland Baltimore County have made an important discovery about how cells move through tissues, combining mathematical modeling with advanced imaging to show that physical shape and chemical signals interact. The study's findings could inform new strategies for controlling cell movement via medical tre...

SourceUniversity of Maryland Baltimore County·JournaliScience·TypeExperimental study·DateMay 28, 2025

City of Hope researchers to present cancer advances that could boost survival at the American Society of Clinical Oncology (ASCO) Annual Meeting

Researchers from City of Hope will present novel cancer treatment approaches and combinations, including innovative combination therapies for breast, genitourinary, and gastrointestinal cancers. Additionally, they'll discuss the safety of readministering trastuzumab-deruxtecan to metastatic breast cancer patients with low-grade lung co...

MSK Research Highlights May 19, 2025

Researchers at MSK uncovered a key signaling molecule involved in the body's immune response against leptomeningeal metastasis. A new grading system to assess thrombocytopenia risk after CAR T cell therapy was also developed. Additionally, a statistical method called UnitedMet estimates metabolic characteristics from challenging clinic...

Scientists develop super strong antibodies for new cancer treatment

Researchers from the University of Southampton engineered a new type of super-strong antibody that triggers a stronger response from the immune system compared to naturally produced antibodies. The study confirms that making subtle increases in rigidity stimulates immune activity, creating a powerful immune response against disease.

SourceUniversity of Southampton·JournalNature Communications·TypeExperimental study·DateMay 1, 2025

IGTP-led study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

A study led by IGTP identifies an epigenetic signature of 156 altered CpG sites in primary tumours that can help stratify patients according to their risk of developing distant metastases. The findings contribute to a better understanding of the disease and open new avenues for patient stratification and personalised treatment strategies.

SourceGermans Trias i Pujol Research Institute·JournalThyroid·TypeData/statistical analysis·DateApr 25, 2025

New research in JNCCN finds stark disparities in treatment and survival time for people with pancreatic cancer

Researchers found significant disparities in quality of care and outcomes for patients with metastatic pancreatic cancer. Patients with higher social vulnerability indices were less likely to receive guideline-concordant systemic therapy, palliative care, or survive over 12 months.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateApr 9, 2025

circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1/Hippo signaling pathway

A novel circular RNA, circTP63-N, generated by back-splicing exons 2–4 of the TP63 gene is significantly downregulated in nasopharyngeal carcinoma (NPC) tissues. Restoring its expression effectively inhibits NPC cell proliferation and metastasis via engagement with HSP90AB1 to modulate the YAP1/Hippo signaling pathway.

SourceScience China Press·JournalScience China Life Sciences·DateApr 3, 2025

HKU researchers uncover key mechanisms driving oral cancer spread and highlight potential treatment strategies

Researchers from HKU discover critical molecular changes that drive metastasis to lymph nodes and suppress immune responses, offering promising avenues for new treatment approaches. The study highlights the role of the protein POSTN and TGF-β signaling in tumor progression and immune evasion.

SourceThe University of Hong Kong·JournalClinical and Translational Medicine·TypeExperimental study·DateMar 18, 2025